These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24732433)

  • 1. Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.
    Nagalingam A; Kuppusamy P; Singh SV; Sharma D; Saxena NK
    Cancer Res; 2014 May; 74(9):2617-29. PubMed ID: 24732433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1.
    Oh YT; Liu X; Yue P; Kang S; Chen J; Taunton J; Khuri FR; Sun SY
    J Biol Chem; 2010 Dec; 285(53):41310-9. PubMed ID: 21044953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant activation of ETS-like transcription factor-1 and Death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice.
    Kuppusamy P; Nagalingam A; Muniraj N; Saxena NK; Sharma D
    Sci Rep; 2017 Dec; 7(1):17943. PubMed ID: 29263422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of ERK1/2-mediated ELK1/CHOP/DR5 pathway in 6-(methylsulfinyl)hexyl isothiocyanate-induced apoptosis of colorectal cancer cells.
    Yano S; Wu S; Sakao K; Hou DX
    Biosci Biotechnol Biochem; 2019 May; 83(5):960-969. PubMed ID: 30730256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKCδ regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cells.
    Xu L; Su L; Liu X
    Mol Cancer Ther; 2012 Oct; 11(10):2174-82. PubMed ID: 22848091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
    Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
    Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
    Park SK; Sanders BG; Kline K
    Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5.
    Fei HR; Yuan C; Wang GL; Zhao Y; Li ZJ; Du X; Wang FZ
    Phytomedicine; 2019 Sep; 62():152950. PubMed ID: 31102888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway.
    Yi L; Zongyuan Y; Cheng G; Lingyun Z; Guilian Y; Wei G
    Cancer Sci; 2014 May; 105(5):520-7. PubMed ID: 24612139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
    Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Ras and B-Raf proteins positively regulate death receptor 5 expression through co-activation of ERK and JNK signaling.
    Oh YT; Yue P; Zhou W; Balko JM; Black EP; Owonikoko TK; Khuri FR; Sun SY
    J Biol Chem; 2012 Jan; 287(1):257-267. PubMed ID: 22065586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-CHOP-death receptor pathway.
    Gupta SC; Francis SK; Nair MS; Mo YY; Aggarwal BB
    J Biol Chem; 2013 Nov; 288(45):32343-32356. PubMed ID: 24078627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.
    Lee YS; Lee DH; Jeong SY; Park SH; Oh SC; Park YS; Yu J; Choudry HA; Bartlett DL; Lee YJ
    J Cell Biochem; 2019 Jan; 120(1):928-939. PubMed ID: 30160785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway.
    Guo X; Meng Y; Sheng X; Guan Y; Zhang F; Han Z; Kang Y; Tai G; Zhou Y; Cheng H
    Anticancer Drugs; 2017 Jan; 28(1):66-74. PubMed ID: 27603596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vernodalol enhances TRAIL-induced apoptosis in diffuse large B-cell lymphoma cells.
    Wu W; Yang Y; Deng G; Ma L; Wei G; Zheng G; Han X; He D; Zhao Y; He J; Cai Z; Yu R
    Mol Carcinog; 2017 Oct; 56(10):2190-2199. PubMed ID: 28467689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway.
    Gopalan A; Yu W; Sanders BG; Kline K
    Cancer Lett; 2013 Feb; 329(1):9-16. PubMed ID: 22960596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy.
    Wang J; Wang H; Wang LY; Cai D; Duan Z; Zhang Y; Chen P; Zou JX; Xu J; Chen X; Kung HJ; Chen HW
    Cell Death Differ; 2016 Nov; 23(11):1886-1896. PubMed ID: 27612013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer.
    Serra V; Eichhorn PJ; García-García C; Ibrahim YH; Prudkin L; Sánchez G; Rodríguez O; Antón P; Parra JL; Marlow S; Scaltriti M; Pérez-Garcia J; Prat A; Arribas J; Hahn WC; Kim SY; Baselga J
    J Clin Invest; 2013 Jun; 123(6):2551-63. PubMed ID: 23635776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.
    Hsu YL; Hou MF; Kuo PL; Huang YF; Tsai EM
    Oncogene; 2013 Sep; 32(37):4436-47. PubMed ID: 23045282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.